Vascular dementia (VaD) is a type of dementia caused by reduced blood flow to the brain, often due to strokes or small vessel disease.
Alzheimer’s disease is a progressive neurodegenerative disorder that leads to memory loss, cognitive decline, and behavioral changes.
Posterior Cortical Atrophy (PCA) is a rare neurodegenerative condition that primarily affects the brain’s posterior cortex, the region responsible for processing visual information.
Korsakoff Syndrome is a severe memory disorder caused by long-term thiamine (vitamin B1) deficiency, most commonly associated with chronic alcohol abuse.
Lewy Body Dementia (LBD) is a progressive neurological disorder caused by the buildup of abnormal protein deposits, called Lewy bodies, in the brain.
Frontotemporal Dementia (FTD) is a type of dementia that primarily affects the frontal and temporal lobes of the brain. Unlike Alzheimer’s, which mainly impacts memory, FTD is often associated with significant changes in personality, behavior, and language. FTD is the most common form of dementia for people under the age of 60, making it a crucial but often misunderstood condition. In this article, we’ll explore the symptoms, causes, diagnosis, and treatment options available for FTD, along with what sets it apart from other dementias.
Imagine a form of dementia that mimics Alzheimer’s symptoms but progresses so rapidly that death can occur within 12 to 24 months. This is the terrifying reality of Creutzfeldt-Jakob Disease (CJD)—the deadliest and rarest form of dementia. While the chances of contracting CJD are incredibly low, the disease’s aggressive nature makes it one of the most feared dementias. In this article, we’ll dive into what CJD is, how it’s diagnosed, and why it’s so deadly.
When it comes to Alzheimer’s disease, the key to effective treatment is early detection. But many people ask, ‘Is there a test for Alzheimer’s?’ Thanks to groundbreaking advancements, the answer is yes. At Silver House, we’ve developed the BATWatch™ Protocol—a comprehensive, proactive approach to cognitive health that focuses on monitoring Beta-Amyloid and Tau (BAT) Levels. This includes our BAT Testing—a set of highly accurate blood tests that can detect Alzheimer’s risk before symptoms even begin.
There’s a lot of stigma and fear surrounding Alzheimer’s disease. Often, the terminology itself makes the condition feel overwhelming and hopeless. But what if changing the way we talk about Alzheimer’s could change how people perceive it? At Silver House, we’ve made it our mission to simplify the language around Alzheimer’s, making it less intimidating and easier to understand.
Parkinson’s Disease Dementia (PDD) is the 4th most common form of dementia, accounting for approximately 3% of all dementia cases. It’s most often recognized by the motor symptoms associated with Parkinson’s disease, such as trembling hands or feet, slowness of movement, and stiffness in the arms or legs. However, cognitive impairment eventually becomes a significant issue for those with PDD.